NCT01570244View on ClinicalTrials.gov

Drug-drug Interaction of BI 201335 and Microgynon

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Hepatitis C, Chronic
Interventions
DRUG

levonorgestrel

multiple doses

DRUG

Ethinylestradiol

multiple doses

DRUG

levonorgestrel

multiple doses

DRUG

BI 201335

multiple doses

DRUG

Ethinylestradiol

multiple doses

Trial Locations (1)

Unknown

1220.56.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01570244 - Drug-drug Interaction of BI 201335 and Microgynon | Biotech Hunter | Biotech Hunter